Browsing byAuthor : fangz
Showing results 1 to 3 of 3
-
Publication Date2016-11
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer
Rumman M.; Jung K.H.; Fang Z., et al
ONCOTARGET, v.7, no.47, pp.78029 - 78047
-
Publication Date2015-01
HS-543 induces apoptosis of imatinib-resistant chronic myelogenous leukemia with T315I mutation
Kim S.J.; Jung K.H.; Yan H.H., et al
ONCOTARGET, v.6, no.3, pp.1507 - 1518
-
Publication Date2016-11
Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects
Yongje Shin; Sang Min Lim; Yan H.H., et al
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.123, pp.544 - 556
1